HUT51143A - Process for production of homogenisate of piroxicame and capsule or pill made from it - Google Patents

Process for production of homogenisate of piroxicame and capsule or pill made from it

Info

Publication number
HUT51143A
HUT51143A HU885621A HU562188A HUT51143A HU T51143 A HUT51143 A HU T51143A HU 885621 A HU885621 A HU 885621A HU 562188 A HU562188 A HU 562188A HU T51143 A HUT51143 A HU T51143A
Authority
HU
Hungary
Prior art keywords
piroxicame
homogenisate
capsule
production
pill made
Prior art date
Application number
HU885621A
Other languages
Hungarian (hu)
Other versions
HU200926B (en
Inventor
Pal Fekete
Denes Bezzegh
Istvan Simonyi
Laszlone Maroshelyi
Jozsefne Zukovics
Janos Tombor
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Priority to HU885621A priority Critical patent/HU200926B/en
Priority to JP1270514A priority patent/JPH02172918A/en
Priority to IT22164A priority patent/IT1239542B/en
Priority to FR8914117A priority patent/FR2638357B1/en
Priority to AT0247489A priority patent/AT399277B/en
Priority to CA002001673A priority patent/CA2001673C/en
Priority to IL9213889A priority patent/IL92138A/en
Priority to GB8924286A priority patent/GB2224207B/en
Priority to DE3936112A priority patent/DE3936112C2/en
Publication of HUT51143A publication Critical patent/HUT51143A/en
Publication of HU200926B publication Critical patent/HU200926B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HU885621A 1988-10-28 1988-10-28 Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules HU200926B (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
HU885621A HU200926B (en) 1988-10-28 1988-10-28 Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules
JP1270514A JPH02172918A (en) 1988-10-28 1989-10-19 Drug containing n-(2-pyridyl)-2- methyl-4-hydroxy-2h-1,2-benzothiazin- 3-carbooxamide-1,1-dioxide and preparation thereof
IT22164A IT1239542B (en) 1988-10-28 1989-10-27 PHARMACEUTICAL COMPOSITION INCLUDING PIROXICAM AND PROCEDURE FOR LASUA PREPARATION
FR8914117A FR2638357B1 (en) 1988-10-28 1989-10-27 PHARMACEUTICAL COMPOSITION COMPRISING PIROXICAM AND PROCESS FOR THE PREPARATION THEREOF
AT0247489A AT399277B (en) 1988-10-28 1989-10-27 SOLID PHARMACEUTICAL PIROXICAM PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
CA002001673A CA2001673C (en) 1988-10-28 1989-10-27 Pharmaceutical composition containing piroxicam
IL9213889A IL92138A (en) 1988-10-28 1989-10-27 Pharmaceutical compositions containing piroxicam and their preparation
GB8924286A GB2224207B (en) 1988-10-28 1989-10-27 Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules
DE3936112A DE3936112C2 (en) 1988-10-28 1989-10-30 Medicinal products containing piroxicam and process for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU885621A HU200926B (en) 1988-10-28 1988-10-28 Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules

Publications (2)

Publication Number Publication Date
HUT51143A true HUT51143A (en) 1990-04-28
HU200926B HU200926B (en) 1990-09-28

Family

ID=10970484

Family Applications (1)

Application Number Title Priority Date Filing Date
HU885621A HU200926B (en) 1988-10-28 1988-10-28 Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules

Country Status (9)

Country Link
JP (1) JPH02172918A (en)
AT (1) AT399277B (en)
CA (1) CA2001673C (en)
DE (1) DE3936112C2 (en)
FR (1) FR2638357B1 (en)
GB (1) GB2224207B (en)
HU (1) HU200926B (en)
IL (1) IL92138A (en)
IT (1) IT1239542B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2642486B2 (en) * 1989-08-04 1997-08-20 田辺製薬株式会社 Ultrafine particle method for poorly soluble drugs
JP2964195B2 (en) * 1992-04-28 1999-10-18 エスエス製薬株式会社 Piroxicam tablets and method for producing the same
DE19603402A1 (en) * 1995-02-24 1996-08-29 Basf Ag Soft gelatin capsules
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
PT914818E (en) 1996-06-14 2005-08-31 Kyowa Hakko Kogyo Kk TABLET OF FAST DISINTEGRATION BY INTRAORAL
WO1999052491A1 (en) * 1998-04-08 1999-10-21 Kyowa Hakko Kogyo Co., Ltd. Tablet manufacturing method and tablet
JP2000095674A (en) 1998-09-22 2000-04-04 Sato Pharmaceutical Co Ltd Method and apparatus for producing tablet with reduced oral disintegration time
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US20060018959A1 (en) * 2002-12-16 2006-01-26 Kissei Pharmaceutical Co. Ltd. Solid drug for oral use
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
WO2006047493A2 (en) 2004-10-21 2006-05-04 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
AU2006273378B2 (en) * 2005-07-25 2011-10-13 Otsuka Pharmaceutical Co., Ltd. Oral preparation useful in measuring capacity to metabolize pyridine
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
JP6352188B2 (en) 2012-08-20 2018-07-04 大塚製薬株式会社 Method for measuring sugar metabolic capacity and composition used therefor
KR20210014204A (en) 2013-03-15 2021-02-08 오츠카 세이야쿠 가부시키가이샤 Method of measuring insulin resistance with fatty acid combustion, and composition used herein

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
GB1308533A (en) * 1969-06-02 1973-02-21 Pfizer Benzothiazine dioxides as anti-thombotic agents
JPS55129221A (en) * 1979-03-29 1980-10-06 Kaken Pharmaceut Co Ltd Preparation of oral preparation containing hardly soluble medicine
US4350689A (en) * 1980-02-15 1982-09-21 American Cyanamid Company Combinations of agents which give enhanced anti-inflammatory activity
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
RO88420A (en) * 1983-04-25 1986-01-30 Pfizer Inc,Us PROCEDURE FOR THE PREPARATION OF PIROXICAN BASIC BATCHES EMPTY ON PHARMACEUTICAL SUPPORTS
DE3419128A1 (en) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen DIHYDROPYRIDINE PREPARATIONS AND METHOD FOR THE PRODUCTION THEREOF
CH663899A5 (en) * 1985-03-20 1988-01-29 Nestle Sa PROCESS FOR THE PREPARATION OF A COMPOSITION BASED ON A FINELY DIVIDED LOW HYDROSOLUBILITY ACTIVE INGREDIENT.
ES545221A0 (en) * 1985-07-02 1986-01-01 Ferrer Int PROCEDURE FOR OBTAINING PARTICLES OF 4-HYDROXY-2-METHYL-N-2-PIRIDIL-2H-1,2-BENZOTIAZINE-3-CARBOXAMIDE-1,1-DIOXI-DO (PIROXICAM) COATED

Also Published As

Publication number Publication date
CA2001673A1 (en) 1990-04-28
IT8922164A1 (en) 1991-04-27
IT1239542B (en) 1993-11-05
IL92138A (en) 1994-08-26
FR2638357B1 (en) 1993-10-22
AT399277B (en) 1995-04-25
GB2224207B (en) 1992-06-10
GB2224207A (en) 1990-05-02
DE3936112C2 (en) 1999-02-18
CA2001673C (en) 1996-08-27
DE3936112A1 (en) 1990-05-31
GB8924286D0 (en) 1989-12-13
HU200926B (en) 1990-09-28
FR2638357A1 (en) 1990-05-04
IL92138A0 (en) 1990-07-12
IT8922164A0 (en) 1989-10-27
JPH02172918A (en) 1990-07-04
ATA247489A (en) 1994-09-15

Similar Documents

Publication Publication Date Title
HUT51272A (en) Process for producing thiadiazin derivatives and pharmaceutical composirions containing them
GR890100314A (en) Process for the preparation of drug absorbates
HU904911D0 (en) Process for producing 1hrh analogues of reduced size and pharmaceutical preparatives containing them
HUT48900A (en) Process for producing phosphoruus-containing squalene-synthetase inhibitores and pharmaceutical compositions containing them
HUT53644A (en) Process for producing pharmaceutical nukleozides and pharmaceutical compositions containing them
AU589340B2 (en) Capsule sealing process and product
EP0328041A3 (en) Ceramic implant and process for its production
IL87397A (en) Process of forming shaped articles from preprocessed starch and such articles
HUT48903A (en) Process for production of derivatives of adenosin and medical preparatives containing these substances
HUT45270A (en) Process for production of polipeptides containing nor-statine and nor-cyclostatin
CS614388A2 (en) Method of pharmaceutical agent production
HU903281D0 (en) Process for producing 2-hydroxy-n-propyl-amines and containing them pharmaceutical preparatives
SG99494G (en) Orthorhombic ciclosporin crystal form, process for its production and pharmaceutical containing it
HU894124D0 (en) Process for producing peptides and pharmaceutical preparatives containing these peptides
HUT46907A (en) Process for production of derivatives of 1,4-dihydropiridine and medical preparatives containing such substances
HUT52747A (en) Process for production of derivatives of cycloalcanon and/or cycloalcanol
HUT48904A (en) Process for production of derivatives of 2-substituated adenosin and medical preparatives containing these substances
HUT48587A (en) Process for production of derivatives of piperidin and medical preparatives containing these substances
HUT50121A (en) Process for producing piperidinyl-derivatives and pharmaceutical compositions containing them
HUT45971A (en) Process for production of new alkon-sulphon-anilid and medical preparatives containing such substances
HUT51247A (en) Process for production of aryl-zyanguananidins and medical compositions containing them
HUT52737A (en) Process for production of silicium-nitrid containing big alpha-phase
HUT50167A (en) Process for production of derivatives of tetrasole and medical compositions containing them
HU892651D0 (en) Process for the production of flavoxate derivatives and medical preparations containing thereof
HUT48278A (en) Process for production of rhenin-hindering dipeptides and medical preparatives containing them

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: EGIS GYOGYSZERGYAR NYRT., HU

Free format text: FORMER OWNER(S): EGIS GYOGYSZERGYAR, HU